Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392), a leading biopharmaceutical company based in China, has entered into a strategic partnership with the Fujian Provincial Center for Disease Control and Prevention (FJCDC). This collaboration will focus on enhancing efforts in pathogen detection technology, vaccine development, clinical research, scientific outreach, and talent development. Additionally, the partnership will extend to areas such as vaccine cold chain management and information systems. The financial specifics of the agreement have not been disclosed. -Fineline Info & Tech
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity